Grave_s Disease Introduction
-
Upload
jeremiash-noblesala-dela-cruz -
Category
Documents
-
view
215 -
download
0
Transcript of Grave_s Disease Introduction
-
7/27/2019 Grave_s Disease Introduction
1/7
INTRODUCTION
Graves diseaseis anautoimmune disorder that leads to over activity of the thyroid gland
(hyperthyroidism). An autoimmune is a condition that occurs when the immune systemmistakenly attacks and destroys healthy tissue.
Causes
The thyroid gland is an important organ of theendocrine system. The thyroid gland is located at
the front of the neck above where the collar bones meet. This gland releases the
hormonesthyroxin (T4) andtriiodothyronine(T3), which control bodymetabolism.Controlling
metabolism is important for regulating mood, weight, and mental and physical energy levels.
When the body makes too much thyroid hormone, the condition is called hyperthyroidism. (An
underactive thyroid leads tohypothyroidism.)
Graves disease is the most common cause of hyperthyroidism. It is due to an abnormal immune
system response that causes the thyroid gland to produce too much thyroid hormone. Graves
disease is most common in women over age 20. But the disorder can occur at any age and can
affect men as well.
Symptoms
Younger patients may have these symptoms:
Anxiety Breast enlargement in men (possible) Difficulty concentrating Double vision Eyeballs that stick out (exophthalmos) Eye irritation and tearing Fatigue Frequent bowel movements Goiter (possible) Heat intolerance Increased appetite Increased sweating Insomnia Irregular menstrual periods in women Muscle weakness Nervousness Rapid or irregular heartbeat (palpitations or arrhythmia) Restlessness and difficulty sleeping Shortness of breath with activity
http://www.nlm.nih.gov/medlineplus/ency/article/000816.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000356.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002351.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003517.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003687.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002257.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000353.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003033.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001178.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003094.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003134.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003081.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003212.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003212.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003081.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003134.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003094.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001178.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003033.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000353.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002257.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003687.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003517.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/002351.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000356.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/000816.htm -
7/27/2019 Grave_s Disease Introduction
2/7
Tremor Weight loss (rarely, weight gain)
Older patients may have these symptoms:
Rapid orirregular heartbeat Chest pain Memory loss Weakness and fatigue
Exams and Tests
The health care provider will do a physical exam and may find that you have an increased heart
rate. An exam of your neck may find that your thyroid gland is enlarged (goiter).
Other tests include:
Blood tests to measure levels of TSH, T3, and free T4 Radioactive iodine uptake and scan
This disease may also affect the following test results:
Orbit CT scan or ultrasound Thyroid stimulating immunoglobulin (TSI) Thyroid peroxidase (TPO) antibody Anti-TSH receptor antibody
Treatment
Treatment is aimed at controlling your overactive thyroid. Medicines called beta-blockers are
often used to treat symptoms of rapid heart rate, sweating, and anxiety until the hyperthyroidism
is controlled. Hyperthyroidism is treated with one or more of the following:
Ant thyroid medications Radioactive iodine Surgery
If you have radiation or surgery, you will need to take replacement thyroid hormones for the rest
of your life, because these treatments destroy or remove the gland.
Some of the eye problems related to Graves disease usually improvewhen hyperthyroidism is
treated with medications, radiation, or surgery. Radioactive iodine can sometimes make eye
problems worse. Eye problems are worse in people who smoke, even after the hyperthyroidism is
cured.
http://www.nlm.nih.gov/medlineplus/ency/article/003107.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001101.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001107.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003689.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003785.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003685.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003685.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003785.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003689.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001107.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/001101.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003107.htm -
7/27/2019 Grave_s Disease Introduction
3/7
Sometimes prednisone (a steroid medication that suppresses the immune system) is needed to
reduce eye irritation and swelling.
You may need to tape your eyes closed at night to prevent drying. Sunglasses and eye drops may
reduce eye irritation. In rare cases, surgery or radiation therapy (different from radioactive
iodine) may be needed to prevent further damage to the eye and loss of vision.
Outlook (Prognosis)
Graves disease often responds well to treatment. Thyroid surgery or radioactive iodine usually
will cause an underactive thyroid (hypothyroidism). Without getting the correct dosage of
thyroid hormone replacement, hypothyroidism can lead to:
Depression Mental and physical sluggishness Weight gain
When to Contact a Medical Professional
Call your health care provider if you have symptoms of Graves disease. Also call if your eye
problems or other symptoms get worse or do not improve with treatment.
Go to the emergency room or call the local emergency number (such as 911) if you have
symptoms of hyperthyroidism with:
Decrease in consciousness Fever
Rapid, irregular heartbeat
Aplastic Anemia
Aplastic anemia is a syndrome of bone marrow failure characterized by peripheral pancytopenia
and marrow hypoplasia. Mild macrocytosis is observed in association with stress erythropoiesis
and elevated fetal hemoglobin levels. Paul Ehrlich introduced the concept of aplasticanemia in
1888 when he studied the case of a pregnant woman who died of bone marrow failure. However,
it was not until 1904 that Anatole Chauffard named this disorder aplastic anemia
Staging
Staging of aplastic anemia is based on the criteria of the International Aplastic Anemia Study
Group, as follows:
Blood - Neutrophils less than 0.5 X 109/L; platelets less than 20 X 109/L; reticulocytes less than1% corrected (percentage of actual hematocrit [Hct] to normal Hct)
Marrow - Severe hypocellularity; Moderate hypocellularity, with hematopoietic cellsrepresenting less than 30% of residual cells
http://emedicine.medscape.com/article/198475-overviewhttp://emedicine.medscape.com/article/198475-overview -
7/27/2019 Grave_s Disease Introduction
4/7
Severe aplasia is defined as including any 2 or 3 peripheral blood criteria and either marrow
criterion.
A further subclassification developed after the recognition that individuals with neutrophil
counts lower than 0.2 X 109/L had very severe aplastic anemia (VSAA). This group is less likely
than others to respond to immunosuppressive therapy.
The theoretical basis formarrow failure includes primary defects in or damage to the stem cell orthe marrow microenvironment. The distinction between acquired and inherited disease may
present a clinical challenge, but more than 80% of cases are acquired. In acquired aplastic
anemia, clinical and laboratory observations suggest that this is an autoimmune disease.
On morphologic evaluation, the bone marrow is devoid of hematopoietic elements, showinglargely fat cells. Flow cytometry shows that the CD34 cell population, which contains the stem
cells and the early committed progenitors, is substantially reduced.[2, 4]
Data from in vitro colony-
culture assays suggest profound functional loss of the hematopoietic progenitors, so much so that
they are unresponsive even to high levels of hematopoietic growth factors.
It was hypothesized that aplastic anemia may be due to a defect at various levels such as anintrinsic defect of hematopoietic cells, external injury to hematopoietic cells, and defective
stroma, which is critical for normal proliferation and functioning of hematopoietic cells. Thus,
theoretically, all of these mechanisms could be responsible for aplastic anemia. This theory wasthe basis of many in vitro stem cell culture experiments using a cross-over design in which stem
cells from patients with aplastic anemia were cultured with normal stroma and vice-versa. The
conclusions from these studies led to the understanding that stem cell defect is the central
mechanism in the majority of patients with aplastic anemia.[5, 6]
In patients with severe aplastic anemia (SAA), stromal cells have normal function, includinggrowth factor production. Adequate stromal function is implicit in the success of BMT in
aplastic anemia because the stromal elements are frequently of host origin.
The role of an immune dysfunction was suggested in 1970, when autologous recovery was
documented in a patient with aplastic anemia in whom engrafting failed after BMT. Matheproposed that the immunosuppressive regimen used for conditioning promoted the return of
normal marrow function. Since then, numerous studies have shown that, in approximately 70%
of patients with acquired aplastic anemia, immunosuppressive therapy improves marrow
function.[3, 7, 8, 9, 10]
Immunity is genetically regulated (by immune response genes), and it is also influenced byenvironment (eg, nutrition, aging, previous exposure).
[11, 12]Although the inciting antigens that
breach immune tolerance with subsequent autoimmunity are unknown, human leukocyte antigen
(HLA)-DR2 is overrepresented among European and United States patients with aplastic anemia,suggesting a role for antigen recognition, and its presence is predictive of a better response tocyclosporine.
Suppression of hematopoiesis is likely mediated by an expanded population of the cytotoxic T
lymphocytes (CTLs) CD8 and HLA-DR+, which are detectable in the blood and bone marrow of
patients with aplastic anemia. These cells produce inhibitory cytokines, such as gamma-interferon and tumor necrosis factor, which can suppress progenitor cell growth. Polymorphisms
http://emedicine.medscape.com/article/993616-overviewhttp://emedicine.medscape.com/article/993616-overview -
7/27/2019 Grave_s Disease Introduction
5/7
in these cytokine genes, associated with an increased immune response, are more prevalent in
patients with aplastic anemia. These cytokines suppress hematopoiesis by affecting the mitotic
cycle and cell killing by inducing Fas-mediated apoptosis. In addition, these cytokines inducenitric oxide synthase and nitric oxide production by marrow cells, which contributes to immune-
mediated cytotoxicity and the elimination of hematopoietic cells.
Constitutive expression of Tbet, a transcriptional regulator that is critical to Th1 polarization,occurs in a majority of aplastic anemia patients.
[7]Perforin is a cytolytic protein expressed mainly
in activated cytotoxic lymphocytes and natural-killer cells. Mutations in the perforin gene areresponsible for some cases of familial hemophagocytosis
[13];mutations in SAP, a gene encoding
for a small modulator protein that inhibits undefined-interferon production, underlie X-linked
lymphoproliferation, a fatal illness associated with an aberrant immune response to herpesvirusesand aplastic anemia. Perforin and SAP protein levels are markedly diminished in a majority of
acquired aplastic anemia cases.
Apart from immunological, toxin/drug-related, and infectious etiopathologies, around 10-15% of
patients with apparently acquired aplastic anemia may have shortened telomeres in blood
lymphocytes. This was initially presumed to reflect stressed hematopoiesis, but, subsequently,telomerase gene complex mutations have been demonstrated in such individuals as well as their
healthy family members. These apparently healthy family members were subsequently tested and
found to have normal or near-normal blood counts, along with hypocellular marrowfragments.
[14]
Congenital or inherited causes
Congenital or inherited causes of aplastic anemia (20%) include the following:
Patients usually have dysmorphic features or physical stigmata; on occasion, marrow failuremay be the initial presenting feature.
Fanconi anemia
Dyskeratosis congenita Cartilage-hair hypoplasia Pearson syndrome Amegakaryocytic thrombocytopenia (thrombocytopenia-absent radius [TAR] syndrome) Shwachman-Diamond syndrome Dubowitz syndrome Diamond-Blackfan syndrome Familial aplastic anemia
Acquired causes
Acquired causes of aplastic anemia (80%) include the following:
Idiopathic factors Infectious causes, such as hepatitis viruses, Epstein-Barr virus (EBV), human
immunodeficiency virus (HIV), parvovirus, and mycobacteria
Toxic exposure to radiation and chemicals, such as benzene Transfusional GVHD Orthotopic liver transplantation for fulminant hepatitis Pregnancy
http://emedicine.medscape.com/article/960401-overviewhttp://emedicine.medscape.com/article/960401-overview -
7/27/2019 Grave_s Disease Introduction
6/7
Eosinophilic fasciitisDrugs and elements, such as chloramphenicol, phenylbutazone, and gold, may cause aplasia of
the marrow. The immune mechanism does not account for the marrow failure in idiosyncraticdrug reactions. In such cases, direct toxicity may occur, perhaps due to genetically determined
differences in metabolic detoxification pathways. For example, the null phenotype of certain
glutathione transferases is overrepresented among patients with aplastic anemia.Paroxysmal nocturnal hemoglobinuria (PNH) is caused by an acquired genetic defect limited to
the stem-cell compartment affecting the PIGAgene. Mutations in the PIGAgene render cells ofhematopoietic origin sensitive to increased complement lysis. Approximately 20% of patients
with aplastic anemia have evidence of PNH at presentation, as detected by means of flow
cytometry. Furthermore, patients whose disease responds after immunosuppressive therapyfrequently recover with clonal hematopiesis and PNH.
Hypertension
Hypertension (HTN) affects approximately 50 million individuals in the United States and 1
billion worldwide. Unless broad and effective preventive measures are implemented, the
prevalence of hypertension will continue to increase.[1]
Hypertension is a major modifiable risk
factor for cardiovascular disease (CVD). Current trends indicate hypertension is often
undertreated and associated with poor medication and lifestyle adherence. Pharmacists play an
important role then in providing patient education, identifying barriers to medication adherence,
and assisting the patient in developing plans to address and improve adherence.
Numerous antihypertensive agents are available and should be tailored to address specific patient
characteristics. The pharmacist's knowledge of evidence-based primary literature,
pharmacokinetics, and when a particular class of antihypertensive agent provides greater benefit
plays an important role in the recommendation and selection of appropriate cost-effective
antihypertensive agents.The following treatment guidelines are adapted from the Seventh Report
of the Joint National Committee on the Diagnosis, Evaluation, and Treatment of Hypertension
for Classifying and Defining Blood Pressure levels for Adults (18 years and older).
Congestive heart failure occurs when the heart is not strong enough to pump blood efficientlyaround the body, causing fluid to collect in the lungs and body tissue, which leads to congestion.
Heart failure becomes increasingly common with age.
Congestive heart failure does not mean that the heart stops. It is a long-term condition that can bekept under control for many years with medication and lifestyle changes.
Blood
Blood supplies oxygen to the body and removes carbon dioxide. It is pumped around the body bythe heart.
-
7/27/2019 Grave_s Disease Introduction
7/7
LungsLungs are a pair of organs in the chest that control breathing. They remove carbon dioxide from
the blood and replace it with oxygen.
Tissue
Body tissue is made up of groups of cells that perform a specific job, such as protecting the body
against infection, producing movement or storing fat.
CongestionCongestion is an excess of fluid in part of the body, often causing a blockage.